loader2
Partner With Us NRI

Company details

26.95
28.90
21.65
55.65
6M Return -0.54%
1Y Return 27.08%
Mkt Cap.(Cr) 13.71
Volume 7,904
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 7,904

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 5.70 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 28,019.57 -43,282.61
LAST 3M 77,901.94 -49,701.23
LAST 6M 142,324.16 -198,923.20
LAST 12M 202,461.29 -168,761.49
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
14.79
58.5%
11.9524
17.07%
19.2%
Description
  • Emmessar Biotech & Nutrition Ltd, originally started on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started with its operations manufacturing Super Specialty Fine Chemicals. In its in-house R&D, the Company succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated. ECIL`s research team established that the specialty chemicals made by them had potential as `Vital Micro Nutrients`, used worldwide in research as `tools` of Biotechnology. The Company`s management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer`s and consumer`s minds. To better represent its new core activity, a change in the company`s name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, became essential. EBNL`s R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the USA. The intellectual exchange of concepts and technology between Emmessar Biotech & Nutrition Ltd., and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving a new dimension to future products emerging from the stable. EBNL`s range of products covers different aspects and unmet needs of Healthcare. They cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments. EBNL is a Public Limited Company, with a paid-up Share Capital of about Rs. 50.00 million (over US$ 1.00 million). The Company`s stocks are traded on The Bombay Stock Exchange Ltd.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524768
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE634B01016

ICICIdirect Emmessar Biotech & Nutrition Ltd FAQ

You can buy Emmessar Biotech & Nutrition Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Emmessar Biotech & Nutrition Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 18, 2022 04:01 PM the closing price of Emmessar Biotech & Nutrition Ltd was ₹ 27.45.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 18, 2022 04:01 PM, the market cap of Emmessar Biotech & Nutrition Ltd stood at ₹ 13.71.
The latest PE ratio of Emmessar Biotech & Nutrition Ltd as of May 18, 2022 04:01 PM is 14.79
The latest PB ratio of Emmessar Biotech & Nutrition Ltd as of May 18, 2022 04:01 PM is 0.42
The 52-week high of Emmessar Biotech & Nutrition Ltd is ₹ 55.65 while the 52-week low is ₹ 21.65 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE